222 related articles for article (PubMed ID: 22678855)
1. Indications for heart transplantation in current era of left ventricular assist devices.
Milla F; Pinney SP; Anyanwu AC
Mt Sinai J Med; 2012; 79(3):305-16. PubMed ID: 22678855
[TBL] [Abstract][Full Text] [Related]
2. Immunologic sensitization in recipients of left ventricular assist devices.
John R; Lietz K; Schuster M; Naka Y; Rao V; Mancini DM; Rose EA; Smith CR; Oz MC; Edwards NM; Itescu S
J Thorac Cardiovasc Surg; 2003 Mar; 125(3):578-91. PubMed ID: 12658200
[TBL] [Abstract][Full Text] [Related]
3. Ventricular assist device support as a bridge to heart transplantation in patients with giant cell myocarditis.
Murray LK; González-Costello J; Jonas SN; Sims DB; Morrison KA; Colombo PC; Mancini DM; Restaino SW; Joye E; Horn E; Takayama H; Marboe CC; Naka Y; Jorde UP; Uriel N
Eur J Heart Fail; 2012 Mar; 14(3):312-8. PubMed ID: 22265922
[TBL] [Abstract][Full Text] [Related]
4. Left ventricular assist devices decrease fixed pulmonary hypertension in cardiac transplant candidates.
Zimpfer D; Zrunek P; Roethy W; Czerny M; Schima H; Huber L; Grimm M; Rajek A; Wolner E; Wieselthaler G
J Thorac Cardiovasc Surg; 2007 Mar; 133(3):689-95. PubMed ID: 17320566
[TBL] [Abstract][Full Text] [Related]
5. Transcutaneous energy transmission for mechanical circulatory support systems: history, current status, and future prospects.
Slaughter MS; Myers TJ
J Card Surg; 2010 Jul; 25(4):484-9. PubMed ID: 20642765
[TBL] [Abstract][Full Text] [Related]
6. Seven years' experience with the Pierce-Donachy ventricular assist device.
Pennington DG; Kanter KR; McBride LR; Kaiser GC; Barner HB; Miller LW; Naunheim KS; Fiore AC; Willman V
J Thorac Cardiovasc Surg; 1988 Dec; 96(6):901-11. PubMed ID: 3057290
[TBL] [Abstract][Full Text] [Related]
7. Left ventricular assist device as bridge to transplantation does not adversely affect one-year heart transplantation survival.
Cleveland JC; Grover FL; Fullerton DA; Campbell DN; Mitchell MB; Lindenfeld J; Wolfel EE; Lowes BD; Shakar SF; Brieke A; Cannon A; Robertson AD
J Thorac Cardiovasc Surg; 2008 Sep; 136(3):774-7. PubMed ID: 18805284
[TBL] [Abstract][Full Text] [Related]
8. Cardiac extracorporeal life support: state of the art in 2007.
Cooper DS; Jacobs JP; Moore L; Stock A; Gaynor JW; Chancy T; Parpard M; Griffin DA; Owens T; Checchia PA; Thiagarajan RR; Spray TL; Ravishankar C
Cardiol Young; 2007 Sep; 17 Suppl 2():104-15. PubMed ID: 18039404
[TBL] [Abstract][Full Text] [Related]
9. [Surgical therapy of end-stage heart failure. State of the art 2006].
Klotz S; Loeher A; Drees G; Scheld HH
Herz; 2006 Aug; 31(5):445-54. PubMed ID: 16944064
[TBL] [Abstract][Full Text] [Related]
10. Post-cardiac transplant survival after support with a continuous-flow left ventricular assist device: impact of duration of left ventricular assist device support and other variables.
John R; Pagani FD; Naka Y; Boyle A; Conte JV; Russell SD; Klodell CT; Milano CA; Rogers J; Farrar DJ; Frazier OH
J Thorac Cardiovasc Surg; 2010 Jul; 140(1):174-81. PubMed ID: 20447659
[TBL] [Abstract][Full Text] [Related]
11. Left ventricular assist devices as destination therapy: a new look at survival.
Park SJ; Tector A; Piccioni W; Raines E; Gelijns A; Moskowitz A; Rose E; Holman W; Furukawa S; Frazier OH; Dembitsky W
J Thorac Cardiovasc Surg; 2005 Jan; 129(1):9-17. PubMed ID: 15632819
[TBL] [Abstract][Full Text] [Related]
12. Preoperative predictors of survival in patients with Thoratec ventricular assist devices as a bridge to heart transplantation. Thoratec Ventricular Assist Device Principal Investigators.
Farrar DJ
J Heart Lung Transplant; 1994; 13(1 Pt 1):93-100; discussion 100-1. PubMed ID: 8167132
[TBL] [Abstract][Full Text] [Related]
13. Clinical experience with the Novacor ventricular assist system. Bridge to transplantation and the transition to permanent application.
McCarthy PM; Portner PM; Tobler HG; Starnes VA; Ramasamy N; Oyer PE
J Thorac Cardiovasc Surg; 1991 Oct; 102(4):578-86; discussion 586-7. PubMed ID: 1921434
[TBL] [Abstract][Full Text] [Related]
14. Left ventricular assist device as a bridge to partial left ventriculectomy.
Frazier OH
Eur J Cardiothorac Surg; 1999 Jan; 15 Suppl 1():S20-5; discussion S39-43. PubMed ID: 10077391
[TBL] [Abstract][Full Text] [Related]
15. HeartMate® II continuous-flow left ventricular assist system.
Sheikh FH; Russell SD
Expert Rev Med Devices; 2011 Jan; 8(1):11-21. PubMed ID: 21158536
[TBL] [Abstract][Full Text] [Related]
16. Current status of left ventricular assist devices: the role in bridge to heart transplantation and future perspectives.
Matsuda H; Matsumiya G
J Artif Organs; 2003; 6(3):157-61. PubMed ID: 14598097
[TBL] [Abstract][Full Text] [Related]
17. Successful left ventricular assist device bridge to transplantation in a patient with end-stage heart failure and human immunodeficiency virus.
Krishan K; Pinney S; Anyanwu AC
Artif Organs; 2012 Aug; 36(8):759. PubMed ID: 22748011
[No Abstract] [Full Text] [Related]
18. Duration of left ventricular assist device support affects transplant survival.
Ashton RC; Goldstein DJ; Rose EA; Weinberg AD; Levin HR; Oz MC
J Heart Lung Transplant; 1996 Nov; 15(11):1151-7. PubMed ID: 8956124
[TBL] [Abstract][Full Text] [Related]
19. Duration of inotropic support after left ventricular assist device implantation: risk factors and impact on outcome.
Schenk S; McCarthy PM; Blackstone EH; Feng J; Starling RC; Navia JL; Zhou L; Hoercher KJ; Smedira NG; Fukamachi K
J Thorac Cardiovasc Surg; 2006 Feb; 131(2):447-54. PubMed ID: 16434277
[TBL] [Abstract][Full Text] [Related]
20. Radical alternatives to transplantation.
Starling RC
Curr Opin Cardiol; 1997 Mar; 12(2):166-71. PubMed ID: 9192486
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
